Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
114.48%
-
Total 13F principal
-
$194,112,610
-
Principal change
-
-$406,174,800
-
Total reported market value
-
$223,004,087
-
Number of holders
-
52
-
Value change
-
-$464,181,582
-
Number of buys
-
12
-
Number of sells
-
32
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q4 2019
As of 31 Dec 2019,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
52 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$194,112,610
in principal (par value) of the bond.
The largest 10 bondholders included
MACKAY SHIELDS LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., FMR LLC, Man Group plc, SONORA INVESTMENT MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, CSS LLC/IL, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, and BNP PARIBAS ASSET MANAGEMENT Holding S.A..
This page lists
52
institutional bondholders reporting positions
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.